GSK3B and colorectal cancer: In colorectal cancer cells, β-catenin regulates the activity of the NF-κB promoter [59], whereas inhibition of GSK-3β by lithium or siRNA potentiated TNF-induced expression of IL-6 and CCL2 in human microvascular endothelial cells [60].